Amesite (AMST) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
Annual Meeting scheduled for January 21, 2025, to be held virtually, with voting on two main proposals: election of two Class I directors and ratification of the independent auditor for FY2025.
Proxy materials distributed primarily via Internet to reduce costs and environmental impact, with paper copies available upon request.
Record date for voting eligibility is November 26, 2024, with 2,792,440 shares outstanding, each share entitled to one vote.
Voting matters and shareholder proposals
Shareholders will vote on the election of J. Michael Losh and Richard Ogawa as Class I directors for a three-year term.
Ratification of Turner, Stone & Company, L.L.P. as independent registered public accounting firm for FY ending June 30, 2025.
No other matters are currently scheduled, but proxies may be voted on additional matters at the discretion of the proxy holder.
Shareholder proposals for the 2026 Annual Meeting must be submitted by July 30, 2025, for inclusion in proxy materials.
Board of directors and corporate governance
Board consists of seven directors divided into three classes; four are independent as defined by Nasdaq rules.
Ann Marie Sastry, Ph.D. serves as CEO, President, and Chairman, with board leadership structure reviewed periodically.
Board committees include Audit, Compensation, and Corporate Governance/Nominating, each with defined charters and independent membership.
Board diversity matrix provided, with directors from varied backgrounds and experiences.
Code of business conduct and ethics and corporate governance guidelines are in place and publicly available.
Latest events from Amesite
- NurseMagic™ app drives rapid revenue growth and market adoption in healthcare AI.AMST
Investor presentation6 Feb 2026 - NurseMagic's rapid adoption and scalable AI platform drive strong revenue and market growth.AMST
Investor presentation6 Feb 2026 - Revenue surged but losses persist; going concern and Nasdaq compliance risks remain.AMST
Q2 20266 Feb 2026 - Director and auditor approved; NurseMagic gains traction; strong insider investment.AMST
AGM 202510 Jan 2026 - NurseMagic's rapid adoption and scalable sales model position the company for profitable growth in 2025.AMST
Sidoti Micro-Cap Virtual Conference9 Jan 2026 - Flexible $100M shelf registration targets growth in AI-driven education and healthcare solutions.AMST
Registration Filing16 Dec 2025 - Shelf registration allows up to $100M in flexible offerings to fund AI-driven growth initiatives.AMST
Registration Filing16 Dec 2025 - Vote on director elections and auditor ratification at the January 2025 virtual meeting.AMST
Proxy Filing2 Dec 2025 - Director resignations reduce Class I nominees to one; votes for withdrawn nominee disregarded.AMST
Proxy Filing2 Dec 2025